Lab values Flashcards
Calcium (total and ionized)
8.5- 10.5 mg/dL (total)
4.5-5.1 mg/ dL (ionized)
Calculate corrected calcium if albumin is low (not needed for ionized calcium).
Increase due to calcium supplementation, vitamind D, thiazide diuretics
Decrease due to long term heparin, loop diuretics, bisphosphonates, cinacalcet, systemic steroids, calcitonin, foscarnet, topiramate
Supplement in pregnancy osteoporosis/osteopenia and with certain drugs
Chloride
95-106 mEq/L
Used with other labs to assess acid-base status and fluid balance.
Magnesium
1.3-2.1 mEq/L
increase due to magnesium-containing antacids and laxatives (higher risk with renal impairment)
decrease due to PPIs, diuretics, amphotericin B, foscarnet, echinocandins, diarrhea, chronic alcohol intake
Phosphate
2.3-4.7 mg/dL
increase in chronic kidney disease
decrease due to phosphate binders, foscarnet, oral calcium intake
Potassium
3.5-5 mEq/L
increase due to ACE inhibitors, ARBs, aldosterone receptor antagonists, aliskiren, canagliflozin, cyclosporine, tacrolimus, potassium supplements, sulfamethoxazole/trimethoprim, drospirenone-COC
decrease due to beta 2-agonists, diuretics, insulin, sodium polystyrene sulfonate
Sodium
135-145 mEq/L
increase due to hypertonic saline, tolvaptan, conivaptan
decrease due to carbamazepine, oxcarbazepine, SSRIs, diuretics, desmopressin
Sodium level may require correction when hyperglycemia is present
Bicarbonate
venous: 24-30 mEq/L
arterial: 22-26 mEq/L
Used to assess acid-base status
Increase due to loop diuretics, systemic steroids
decrease due to topiramate, zonisamide, salicylate overdose
Blood Urea Nitrogen
7-20 mg/dL
increase in renal impairment and dehydration. Used with SCr to assess fluid status and renal function
Serum Creatinine
0.6-1.3 mg/dL
increase due to may drugs that impair renal function (aminoglycosides, amphotericin B, cisplatin, colistimethate, cyclosporine, loop diuretics, polymyxin, NSAIDs, radiocontrast dye, tacrolimus, vancomycin
false increase due to sulfamethoxazole/trimethoprim, H2RAs, cobicistat
decrease with low muscle mass, amputation, hemodilution
Glucose
70-110 mg/dL
Anion Gap
5-12 mEq/L
calculated value, often reported on the BMP.
An increased anion gap suggests metabolic acidosis
White blood cells
4,000-11,000 cells/mm3
Can increase as an acute phase reactant, indicating a systemic reaction to inflammation or stress
increase due to systemic steroids, colony stimulating factors, epinephrine
decrease due to clozapine, chemotherapy that targets bone marrow, carbamazepine, cephalosporins, immunosuppresants (DMARDs, biologics), procainamide, vancomycin
Neutrophils
45-73%
Used (w signs + symptoms) to assess the likelihood of acute infection. They are also used (w WBC) in the absolute neutrophil count cl to assess for neutropenia
Neutrophils are also called polymorphonuclear cells or segmented neutrophils
Bands
3-5%
Bands are immature neutrophils released from the bone marrow to fight infection (called ‘left shift’ when elevated)
Eosinophils
0-5%
Increase in drug allergy, asthma, inflammation, parasitic infection
Basophils
0-1%
increase in inflammation, hypersensitivity reactions, leukemia
Lymphocytes
20-40%
increase in viral infections, lymphoma
decrease in bone marrow suppression, HIV or due to systemic steroids
monocytes
2-8%
increase in chronic infections, inflammation, stress
Red blood cells
Males: 4.5-5.5 x 106 cells/ uL
Females: 4.1-4.9 x 106 cells/uL
RBCs have an average life span of 120 days
Increase due to erythropoiesis-stimulating agents (ESAs), smoking, and polycythemia
Decrease due to chemotherapy that targets the bone marrow, low production, blood loss, deficiency anemias (B12, folate), hemolytic anemia, sickle cell anemia
Hemoglobin
Males: 13.5-18 g/dL
Females: 12-16 g/dL
Hgb is the iron containing protein that carries oxygen in RBCs
increase due to ESAs
decrease in anemias and bleeding (drug-induced cuases include anticoagulants, antiplatelets, fibrinolytics)
Hematocrit
Males: 38-50%
Females: 36-46%
Hct mirrors the Hgb result
increase due to ESAs
decrease in anemias and bleeding (drug-induced cuases include anticoagulants, antiplatelets, fibrinolytics)
Mean Corpuscular Volume
80-100 fL
Reflects the size and average volume of RBCs
increase (macrocytic anemia) due to B12 or folate deficiency
decrease (microcytic anemia) due to iron defiviency
Mean Corpuscular Hemoglobin
26-34 pg/cell
Additional tests used in an anemia workup
Mean corpuscular Hgb concentration
31-37 g/dL
Additional tests used in an anemia workup
RBC distribution width
11.5-14.5%
RDW measures the variability in the RBC size
iron
65-150 mcg/dL
increase due to iron supplementation. decrease due to blood loss or poor nutrition
Total iron binding capacity
250-400 mcg/dL
Transferrin
> 200 mg/dL
Transferrin Saturation
Males 15-50%
Females: 12-45%
Ferritin
11-300 ng/mL
Erythropoietin
2-25 mIU/mL
Folic acid (folate)
5-25 mcg/L
decrease due to phenytoin/fosphenytoin, phenobarbital, primidone, methotrexate, sulfamethoxazole/trimethoprim, sulfasalazine
supplement folate in women of childbearing age and alcohol use disorder
Vitamin b12
> 200 pg/mL
decrease due to PPis, metformin, colchicine, chloramphenicol
Methylmalonic Acid
varies
used for futher workup of macrocytic anemia when B12 deficiency is suspected
Reticulocyte
0.5-2.5%
Measures the amount of reticulocytes being made by the bone marrow
increase with blood loss and hemolysis. decrease in untreated anemia, due to iron, folate or B12 deficiency, and with bone marrow suppression
Coombs Test, Direct
Direct antiglobulin test
Negative
used in the diagnosis of immune-mediated hemolytic anemia
Drugs that can cause immune-mediated hemolytic anemia include penicillins and cephalosporins (prolonged use/ high concentrations) isoniazid, levodopa, methyldopa, quinidine, quinine, rifampin and sulfonamides